Atlas Trials

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

Clinical trial NCT04121910 · COMPLETED

Trial details

NCT number
NCT04121910
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumour
Start date
2019-11-07
Primary completion
2020-01-12
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.